Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Twice daily
MoneyWeek
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Four times a week
Look After My Bills
Sign up to our free money-saving newsletter, filled with the latest news and expert advice to help you find the best tips and deals for managing your bills. Start saving today!
Calm investors have made big profits in Europe in recent years, in spite of the eurozone crisis. If you had invested £1,000 in the Jupiter European Opportunities investment trust (LSE: JEO) five years ago, it would now be worth around £3,600.
The fund is the top-performing European investment trust over the period, thrashing its benchmark (the MSCI Europe index rose 93%).
"If you think the recovery in Europe has only begun, this is a good fund in which to participate," says Citywire's Gavin Lumsden. The trust is run by Alexander Darwall, "a stand-out performer" in recent years, according to Lumsden. "His due diligence process is very strong he looks to identify companies with compelling growth traits."
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The trust's performance was especially strong in 2009/2010, when quality growth' companies were in fashion. Over the last year, performance has been more pedestrian roughly in line with its benchmark as many investors have switched to more cyclical stocks, including banks.

On the downside, the fund trades on a small premium of 1.4%. So its market value is slightly higher than the value of its underlying assets. The premium may put off some investors, but Darwall's track record means it should be a good way to benefit from long-term growth in Europe.
| Wirecard | 7.98% |
| Novo Nordisk | 7.37% |
| Reed Elsevier | 7.27% |
| Experian | 6.97% |
| Provident Financial | 6.57% |
| Syngenta | 6.16% |
| Novozymes | 6.06% |
| Croda International | 5.15% |
| Intertek | 5.15% |
| Fresenius | 5.05% |
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.
-
How a ‘great view’ from your home can boost its value by 35%A house that comes with a picturesque backdrop could add tens of thousands of pounds to its asking price – but how does each region compare?
-
What is a care fees annuity and how much does it cost?How we will be cared for in our later years – and how much we are willing to pay for it – are conversations best had as early as possible. One option to cover the cost is a care fees annuity. We look at the pros and cons.
